International Stem Cell CORP (ISCO) Financial Statements (2024 and earlier)
Company Profile
| Business Address |
9745 BUSINESSPARK AVENUE SAN DIEGO, CA 92131 |
| State of Incorp. | DE |
| Fiscal Year End | December 31 |
| Industry (SIC) | 2834 - Pharmaceutical Preparations (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)
| 6/30/2024 MRQ | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments | 1,588 | 742 | 171 | 689 | 484 | 1,075 | |||
| Cash and cash equivalents | 1,588 | 742 | 171 | 689 | 484 | 1,075 | |||
| Receivables | 574 | 747 | 844 | 403 | 1,515 | 651 | |||
| Inventory, net of allowances, customer advances and progress billings | 1,263 | 1,384 | 1,184 | 917 | 1,246 | 1,501 | |||
| Inventory | 1,263 | 1,384 | 1,184 | 917 | 1,246 | 1,501 | |||
| Prepaid expense | |||||||||
| Other current assets | |||||||||
| Other undisclosed current assets | 96 | 90 | 135 | 174 | 207 | 543 | |||
| Total current assets: | 3,521 | 2,963 | 2,334 | 2,183 | 3,452 | 3,770 | |||
| Noncurrent Assets | |||||||||
| Inventory, Noncurrent | 266 | 286 | 372 | 371 | 358 | 805 | |||
| Operating lease, right-of-use asset | 557 | 727 | 868 | 874 | 717 | ✕ | |||
| Property, plant and equipment | 215 | 248 | 384 | 534 | 668 | 469 | |||
| Intangible assets, net (including goodwill) | 800 | 878 | 949 | 1,262 | 1,335 | 2,674 | |||
| Intangible assets, net (excluding goodwill) | 800 | 878 | 949 | 1,262 | 1,335 | 2,674 | |||
| Other undisclosed noncurrent assets | 31 | 33 | 39 | 63 | 90 | 78 | |||
| Total noncurrent assets: | 1,869 | 2,172 | 2,612 | 3,104 | 3,168 | 4,026 | |||
| TOTAL ASSETS: | 5,390 | 5,135 | 4,946 | 5,287 | 6,620 | 7,796 | |||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities | 849 | 830 | 912 | 746 | 1,296 | 1,037 | |||
| Accounts payable | 364 | 322 | 508 | 360 | 654 | 458 | |||
| Accrued liabilities | 485 | 508 | 404 | 386 | 642 | 579 | |||
| Debt | 3,457 | 367 | |||||||
| Due to related parties | ✕ | ✕ | 3,325 | 2,943 | 2,045 | ||||
| Other undisclosed current liabilities | 526 | 480 | 429 | 737 | 250 | 1,995 | |||
| Total current liabilities: | 4,832 | 4,635 | 4,284 | 1,483 | 1,913 | 5,077 | |||
| Noncurrent Liabilities | |||||||||
| Long-term debt and lease obligation: | 950 | 845 | 718 | ||||||
| Liabilities, other than long-term debt | 445 | 720 | 2,475 | 2,370 | 182 | ||||
| Deferred rent credit | 182 | ||||||||
| Due to related parties | ✕ | ✕ | 2,475 | 2,370 | |||||
| Operating lease, liability | 445 | 720 | 950 | 845 | 718 | ✕ | |||
| Other undisclosed noncurrent liabilities | (950) | 517 | 207 | ||||||
| Total noncurrent liabilities: | 445 | 720 | 950 | 3,837 | 3,295 | 182 | |||
| Total liabilities: | 5,277 | 5,355 | 5,234 | 5,320 | 5,208 | 5,259 | |||
| Equity | |||||||||
| Equity, attributable to parent, including: | (4,187) | (4,520) | (4,588) | (4,333) | (2,888) | 2,537 | |||
| Common stock | 8 | 8 | 8 | 8 | 8 | 7 | |||
| Additional paid in capital | 106,276 | 105,812 | 105,413 | 104,769 | 103,490 | 109,188 | |||
| Accumulated deficit | (110,476) | (110,345) | (110,014) | (109,115) | (106,391) | (106,663) | |||
| Other undisclosed equity, attributable to parent | 5 | 5 | 5 | 5 | 5 | 5 | |||
| Other undisclosed equity | 4,300 | 4,300 | 4,300 | 4,300 | 4,300 | ||||
| Total equity: | 113 | (220) | (288) | (33) | 1,412 | 2,537 | |||
| TOTAL LIABILITIES AND EQUITY: | 5,390 | 5,135 | 4,946 | 5,287 | 6,620 | 7,796 | |||
Income Statement (P&L) ($ in thousands)
| 6/30/2024 TTM | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | ||
|---|---|---|---|---|---|---|---|---|
| Revenues | 7,789 | 8,180 | 7,176 | 7,128 | 9,472 | 11,089 | ||
| Cost of revenue | (3,181) | (3,269) | (2,935) | (2,781) | (3,933) | (4,069) | ||
| Gross profit: | 4,608 | 4,911 | 4,241 | 4,347 | 5,539 | 7,020 | ||
| Operating expenses | (5,271) | (5,094) | (6,162) | (7,165) | (11,267) | (10,494) | ||
| Other undisclosed operating income | ||||||||
| Operating loss: | (663) | (183) | (1,921) | (2,818) | (5,728) | (3,474) | ||
| Nonoperating income (expense) | 532 | (148) | 1,022 | 94 | 1,463 | 1,343 | ||
| Interest and debt expense | (139) | (135) | 1,009 | (113) | (77) | (48) | ||
| Income (loss) from continuing operations before equity method investments, income taxes: | (270) | (466) | 110 | (2,837) | (4,342) | (2,179) | ||
| Other undisclosed income from continuing operations before income taxes | 139 | 48 | ||||||
| Income (loss) from continuing operations: | (131) | (466) | 110 | (2,837) | (4,342) | (2,131) | ||
| Income (loss) before gain (loss) on sale of properties: | ✕ | ✕ | ✕ | 110 | (2,837) | (4,342) | (2,131) | |
| Other undisclosed net income (loss) | 135 | (1,009) | 113 | 77 | ||||
| Net loss: | (131) | (331) | (899) | (2,724) | (4,265) | (2,131) | ||
| Other undisclosed net income attributable to parent | ||||||||
| Net loss attributable to parent: | (131) | (331) | (899) | (2,724) | (4,265) | (2,131) | ||
| Undistributed earnings (loss) allocated to participating securities, basic | ||||||||
| Other undisclosed net income available to common stockholders, basic | ||||||||
| Net loss available to common stockholders, diluted: | (131) | (331) | (899) | (2,724) | (4,265) | (2,131) | ||
Comprehensive Income ($ in thousands)
| 6/30/2024 TTM | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | ||
|---|---|---|---|---|---|---|---|---|
| Net loss: | (131) | (331) | (899) | (2,724) | (4,265) | (2,131) | ||
| Comprehensive loss, net of tax, attributable to parent: | (131) | (331) | (899) | (2,724) | (4,265) | (2,131) | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.